Reviewed by PillSeek Editorial Team · Last updated
About This Medication
This medication is a White Oval 17 mm, Film coated tablet with imprint "GXFC3". It contains Lamivudine 150 mg / zidovudine 300 mg of Lamivudine[lamivudine] / zidovudine[zidovudine]. This belongs to the Human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor pharmacologic class. It is manufactured by GlaxoSmithKline LLC. For details please contact your physician.
Basic Information
- Imprint
- GXFC3
- Color
- White
- Shape
- Oval
- Size
- 17 mm
Drug Information
- Strength
- Lamivudine 150 mg / zidovudine 300 mg
- Dosage Form
- Film coated tablet
- RxCUI
- 213088
Pharmaceutical Classification
Related Medications
Other drugs in the same class: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- AbacavirABACAVIR SULFATE 300 mg;YELLOW • CAPSULE
- COMBIVIRLAMIVUDINE 150 mg;ZIDOVUDINE 300 mg;WHITE • OVAL
- DidanosineDIDANOSINE 200 mg;GREEN;WHITE • CAPSULE
- DidanosineDIDANOSINE 250 mg;BLUE;WHITE • CAPSULE
- DidanosineDIDANOSINE 400 mg;RED;WHITE • CAPSULE
- EmtrivaEMTRICITABINE 200 mg;WHITE • CAPSULE
- EPIVIRLAMIVUDINE 100 mg;YELLOW • OVAL
- EPIVIRLAMIVUDINE 150 mg;WHITE • DIAMOND
- EPIVIRLAMIVUDINE 300 mg;GRAY • DIAMOND
- EPZICOMABACAVIR SULFATE 600 mg;LAMIVUDINE 300 mg;ORANGE • OVAL
Ingredients
- Active Ingredients
- Lamivudine[lamivudine] / zidovudine[zidovudine]
- Inactive Ingredients
- Colloidal silicon dioxide / hypromelloses / magnesium stearate / cellulose, microcrystalline / polyethylene glycol / polysorbate 80 / sodium starch glycolate type a potato / titanium dioxide
Additional Information
- Manufacturer
- GlaxoSmithKline LLC
- Status (Rx/OTC)
- Rx
- Brand Names
- Combivir
Browse Related Pills
⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.